
InvVax, Inc.: A California-based pharmaceutical company specializing in global pandemic prevention vaccines.
InvVax, Inc. is a California-based pharmaceutical startup founded with the mission to develop and commercialize vaccines aimed at preventing global pandemics. The company's core vision is to create next-generation vaccines using proprietary and novel solutions, starting with influenza. Leveraging technology discovered at UCLA, InvVax focuses on innovative approaches to vaccine development that promise to revolutionize pandemic prevention.
Notable affiliated individuals include researchers and scientists from UCLA who contributed to the foundational technology. InvVax has garnered attention for its patented universal advanced vaccine technology, which has the potential to significantly impact global health by offering more effective and comprehensive protection against infectious diseases. The company's achievements in vaccine innovation position it as a key player in the pharmaceutical industry, particularly in the realm of pandemic prevention.

PaxVax

Uvax Bio
uvaxbio.com

Centivax
centivax.com

Innovac Therapeutics
innovactx.com

Pathovax
pathovax.com

Inventprise
inventprise.com

FruitVaccine
fruitvaccine.org

Epivax
epivax.com

Imvax
imvax.com

VitriVax
vitrivaxbio.com

Solaris Vaccines
solarisvax.com

Vaxxinity
vaxxinity.com

Cancervax
cancervax.com

Novavax
novavax.com

Altravax
altravax.com
Companies similar to InvVax include PaxVax, Uvax Bio, Centivax and Innovac Therapeutics.
InvVax was founded in 2012.
InvVax's headquarters is located in Los Angeles, CA, US.
InvVax's most recent funding round was for $255.9k (USD) in February 2022.
As of Feb 18, 2022, InvVax has raised a total of $255.9k (USD).
InvVax has 5 employees as of Feb 5, 2024.